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μ1-opioid receptorsThe present work aimed to investigate the effects of acute sucrose treatment on the perception of painful
stimuli. Speciﬁcally, we sought to determine the involvement of the endogenous opioid peptide-mediated
system as well as the role of the μ1-opioid receptor in antinociception organisation induced by acute sucrose
intake. Nociception was assessed with the tail-ﬂick test in rats (75, 150 and 250 g) of different ages acutely
pre-treated with 500 μL of a sucrose solution (25, 50, 150 and 250 g/L) or tap water. Young and Adult rats
(250 g) showed antinociception after treatment with 50 g/L (during 5 min) and 150 g/L and 250 g/L (during
20 min) sucrose solutions. Surprisingly, this antinociception was more consistent in mature adult rodents
than in pups. To evaluate the role of opioid systems, mature adult rodents were pre-treated with different
doses (0.25, 1 or 4mg/kg) of the non-selective opioid receptor antagonist naloxone, the selective μ1-opioid
receptor antagonist naloxonazine or vehicle followed by 250 g/L sucrose solution treatment. Sucrose-
induced antinociception was reduced by pre-treatment with both naloxone and naloxonazine. The present
ﬁndings suggest that sweet substance-induced hypo-analgesia is augmented by increasing sucrose concentra-
tions in young and adult rodents. Acute oral sucrose treatment inhibits pain in laboratory animal by mediating
endogenous opioid peptide and μ1-opioid receptor actions.
© 2011 Elsevier Inc. Open access under the Elsevier OA license.1. Introduction
There is evidence that the consumption of sweet palatable sub-
stances produces analgesia in animals (Holder, 1988; Blass and Shide,
1994; Segato et al., 1997; Irusta et al., 2001; Anseloni et al., 2002).
Furthermore, concentrated sucrose solutions seem to reduce crying
and other pain-related behaviours in healthy human infants and su-
crosemay be a safe and useful analgesic forminor surgical interventions
in full-term infants (Haouari et al., 1995; Abad et al., 1996).
There is evidence for antinociception and c-fos immunoreactivity
in endogenous opioid- and monoamine-containing cell groups of
the mesencephalon and pons after an intraoral sucrose infusion in
infant rats (Anseloni et al., 2002). It has been demonstrated that
sweet substances may also increase the analgesic properties ofatomia & Neuropsicobiologia,
Ribeirão Preto da Universidade
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a).
vier OA license.opiates (Lieblich et al., 1983; Marks-Kaufman et al., 1988; Roane
and Martin, 1990; Kanarek et al., 1991), and morphine produces
dose-dependent increases in antinociception elicited by palatable
substances (Kanarek et al., 2000). In fact, palatable substances, such
as sucrose and saccharin, may interact with the opioid system, mod-
ifying its sensitivity (Davis et al., 1956; Lieblich et al., 1983; Bergmann
et al., 1985; Blass and Fitzgerald, 1988; Klein and Green, 1988; Marks-
Kaufman et al., 1988; Roane and Martin, 1990; Rebouças et al., 2005).
The bi-directional relation between endogenous opioids and inges-
tion of sweet substances has motivated research examining a possible
link between intake of sweet substances and antinociception. The
consumption of sweet food has been shown to modulate μ- and κ-
opioid receptors (Kanarek et al., 1997a,b). Some publications have
reported that orogustatory and orotactile analgesia are absent or mini-
mal at postnatal day 0 (P0) and appear consistently from P3 to P10–P17
(Anseloni et al., 2002, 2004). However, other studies found sweetened
substances caused persistent opioid and non-opioid analgesia in adult
rats (Segato et al., 1997; Irusta et al., 2001; Miyase et al., 2005;
Rebouças et al., 2005; Kishi et al., 2006). To date, the same phenomenon
has not been consistently demonstrated in adult humans.
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endogenous opioid polypeptide-mediated system and the role exerted
by μ1-opioid receptors in antinociception induced by the acute intake
of sucrose in an animal model of pain.
2. Material and methods
2.1. Animals
Two hundred male Wistar rats (Rattus norvegicus, Rodentia,
Muridae) (n=8 per group) weighing 75 g, 150 g or 250 g from the
Animal Facility of the School ofMedicine of Ribeirão Preto of theUniver-
sity of São Paulo (FMRP-USP)were used. These animals were housed in
groups (four per cage) and given free access to food and tap water until
the beginning of the experiment. Rats were individually tested when
given the sucrose solution of tap water during experimental
approaches. They were acclimated to the experimental room for 72 h
prior to the experiment (12 h light/12 h dark cycle, lights on at 7 a.m.,
at 23–25 °C). All experiments were performed in accordance with the
recommendations of the Commission of Ethics in Animal Experimenta-
tion of the FMRP-USP (proc. 197/2008), which is in agreement with the
ethical principles in animal research adopted by the Brazilian College of
Animal Experimentation (COBEA) and approved by the Commission of
Ethics in Animal Research (CETEA) in 30/3/2009.
2.2. Antinociceptive tests
After three consecutive days of handling for habituation; nocicep-
tion thresholds were assessed with the tail-ﬂick test. Each animal was
placed in a restraining apparatus (Insight, Brazil) with acrylic walls,
and its tail was placed on a heat source (tail-ﬂick Analgesia Instrument;
Insight, Brazil) that automatically sensed when the animal removed its
tail from the apparatus. The current raised the temperature of the coil
(Ni/Cr alloy; 26.04 cm in length×0.02 cm in diameter) at the rate of
9 °C/s (Prado and Roberts, 1985) starting from room temperature
(approximately 20 °C) for all animals. A small current intensity adjust-
ment could be made at the beginning of the experiment (baseline), if
necessary, to obtain three consecutive tail-ﬂick latencies (TFL) between
2.5 s and 3.5 s. If the animal did not remove its tail from the heater
within 6 s the apparatus was turned off to prevent damage to the skin.
Three baselines of control tail-ﬂick latencies were taken at 5-min
intervals. Tail-ﬂick latencies were also measured following the acute
treatment with various concentrations of sucrose solution. The exper-
iments were performed at 7 a.m., the time when sucrose-induced
antinociception has its maximum effect, according to the literature
(Segato et al., 2005).
2.3. Procedure
We have previously published studies on sweet substance-induced
analgesia in adult rats (Segato et al., 1997; Segato et al., 2005; Irusta et
al., 2001; Rebouças et al., 2005; Miyase et al., 2005; Kishi et al., 2006)
weighing 250 g (mature adult rats). In the conditions of our animal
house, this weight corresponds to an average of 42 post-natal days,
but there is evidence in the literature that sucrose-induced analgesia
occurs mainly in infants (Pepino and Mennella, 2005). Therefore, we
decided to include animals at different ages. The value of 75 g was
chosen (approximately 22 days) because this is the average weight of
pups on the ﬁrst day of weaning. The value of 150 g (young adult rats;
approximately 32 days) was chosen as an intermediate age between
22 and 42 day old rats.
Initially, the animals were submitted to a three day-habituation pe-
riod to new housing conditions of the animal facility of the Department
of Pharmacology of the FMRP-USP, with food and water ad libitum.
Next, they were submitted to a new habituation period for handling
and habituation to the restraining cylinder for another three-day period(15 min/day) in the laboratory of Neuroanatomy andNeuropsychobiol-
ogy of the Department of Pharmacology of the FMRP-USPwith food and
water ad libitum, except during the 15 min period when the rats were
kept in the restraining cylinder. After habituation to the experimental
room and procedures, rats were submitted to 3 h of fasting (no food
or water) and pre-treated with different concentrations of sucrose
solution or tap water. In summary, the experimental procedure con-
sisted of assessing the baseline in the tail-ﬂick test, followed by the
oral administration of tap water (control group) or sucrose solution
(25 g/L, 50 g/L, 150 g/L or 250 g/L) in a single volume of 500 μL. The
more dilute solutions were used to avoid a possible stressful effect of
intake of higher concentration sucrose solution in the present non-
choice-based paradigm on nociceptive threshold.
During the treatment, each rat was held to ensure that the total
volume (500 μL) was ingested when it was administered with a micro-
pipette (Capp A/S; Odense, Denmark).
Nociceptive thresholds were measured 10 s after consumption of
sucrose or tap water and again 5, 10, 15, 20, 25 and 30 min after intake.
Only onemeasurewas taken at each time interval after oral administra-
tion of tap water or sucrose solution.
Independent groups of adult rodents were pre-treated with differ-
ent doses (0.25, 1.0 and 4.0 mg/kg) of either the non-selective opioid
receptor antagonist naloxone, the selective μ1-opioid receptor antago-
nist naloxonazine, or vehicle administered intraperitoneally (IP).
Ten min after pretreatment with naloxone or 24 h after pretreatment
with naloxonazine, according to previous reports (Ling et al., 1986;
Osaki et al., 2003), the animals were given a single oral dose of sucrose
solution (250 g/L) in a volume of 500 μL. The rodents were then imme-
diately submitted to the tail-ﬂick test to evaluate nociceptive threshold
oscillations induced by sucrose at 0, 5, 10, 15, 20, 25, and 30 min. Again,
only one measure was taken at each time interval after the single oral
administration of sucrose solution or tap water.
2.4. Drugs
Commercial sucrose (UNIÃO; Brazil) was used in the present exper-
iment. Non-selective opioid antagonist naloxone (Sigma/Aldrich, St.
Louis, MO, USA) and selective μ1-opioid receptor antagonist naloxona-
zine (at 0.25, 1.0 and 4.0 mg/kg) were administered IP.
2.5. Statistical analysis
Data from experiments for determining the temporal window of
sucrose effects in grouped-caged animals were submitted to a repeated
measure analysis of variance (ANOVA). Differences for each time inter-
val were assessed with one-way ANOVAs followed by Duncan's test
(post hoc). Tests for normal distribution (Kolmogorov-Smirnov)
showed Gaussian distribution inside the studied intervals in all
cases. All values were reported as the mean±standard error of mean
(S.E.M.). Pb0.05 was considered statistically signiﬁcant.
3. Results
The study of the sweet substance-induced antinociception in inde-
pendent groups of rats showed that acute sucrose intake increased
the nociceptive threshold from 0 to 5 min in young pre-treated ro-
dents and from 0 to 20 min in adult pre-treated rodents; this effect
was stronger when sucrose was orally administered at 250 g/L, as
shown in Figs. 1–3. After the acute pre-treatment of 75 g rats (P22)
with sucrose, a short-lasting antinociceptive effect was observed.
There were statistically signiﬁcant effects of treatment [F(4,35)=
7.43; pb0.001], but not of time [F(7,27)=2.07; p>0.05] or treatment
vs. time interaction [F(36,120)=1.06; p>0.05]. However, one-way
ANOVAs showed signiﬁcant differences between groups [F(4,35)
varying from 7.57 to 12.14; pb0.001]. The post hoc test showed sta-
tistically signiﬁcant treatment effects from 0 to 5 min after acute
Fig. 1. Transient antinociceptive effect of acute intake (arrow) of sucrose solutions (25 g/L, 50 g/L, 150 g/L, and 250 g/L) in 75 g Wistar rats (P22). Nociceptive thresholds were
recorded using the tail-ﬂick test. Data are presented as the mean±S.E.M.; n=8; *signiﬁcantly different from control, according to one-way ANOVAs followed by Duncan's post
hoc test; +, signiﬁcantly different from 25 g/L sucrose-treated group; #, signiﬁcantly different from 50 g/L sucrose-treated group; ★, signiﬁcantly different from 150 g/L
sucrose-treated group.
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shown in Fig. 1. There were no statistically signiﬁcant differences in
baseline between groups [F(4,35) varying from 0.11 to 0.65; p>0.05].
Interestingly, after acute pretreatment of 150 g rats (P32) and
250 g rats (P42) with sucrose solutions, long-lasting antinociceptive
effects were observed. For 150 g rats pre-treated with sucrose, there
were statistically signiﬁcant effects of treatment [F(4,35)=40.93;
pb0.001], time [F(9,27)=10.54; pb0.001], and treatment vs. time
interaction [F(36,102)=5.30; pb0.001]. One-way ANOVAs showed
signiﬁcant differences between groups [F(4,35) varying from 5.46 to
26.64; pb0.01]. The post hoc test showed statistically signiﬁcant
treatment effects from 0 to 20 min after the acute oral intake of
150 g/L sucrose solution, as shown in Fig. 2. There were no statistically
signiﬁcant differences in baseline between groups [F(4,35) varying
from 0.26 to 1.79; p>0.05].
For 250g rats pre-treated with sucrose, repeated measurement
ANOVA showed that there were statistically signiﬁcant effects of the
treatment [F(4,35)=15.91; pb0.001], time [F(9,27)=7.38; pb0.001],
and treatment vs. time interaction [F(36,102)=2.16; p=0.001] inFig. 2. Long-lasting antinociceptive effect of acute intake (arrow) of sucrose solutions (25 g/
recorded using the tail-ﬂick test. Data are presented as the mean±S.E.M.; n=8; *signiﬁcant
test; +, signiﬁcantly different from 25 g/L sucrose-treated group; #, signiﬁcantly different fro
group.250 g rats pre-treated with sucrose. One-way ANOVAs showed signiﬁ-
cant differences between groups [F(4,35) varying from 8.36 to 15.37;
pb0.0001]. The post hoc test showed statistically signiﬁcant treatment
effects from 0 to 20 min after the acute oral intake of 250 g/L sucrose so-
lution compared to control, as shown in Fig. 3. Therewere no statistically
signiﬁcant differences in baseline between groups [F(4,35) varying from
0.10 to 1.73; p>0.05].
After the IP administration of naloxone, there were statistically
signiﬁcant effects of the treatment [F(4,31)=20.90; pb0.001],
time [F(9,56)=5.05; pb0.05] and treatment vs. time interaction
[F(36,73)=26.24; pb0.001]. One-way ANOVA showed signiﬁcant
differences between groups [F(4,31) varying from 1.98 to 9.16;
pb0.001] from 0 to 30 min. The post hoc test showed signiﬁcantly
decreased antinociception for naloxone (1.0 and 4.0 mg/kg) immedi-
ately after oral administration of sucrose (250 g/L) from 0 to 30 min.
However, IP administration of naloxone at 0.25 mg/kg did not decrease
the sucrose-induced antinociception, as shown in Fig. 4.
Additionally, after the IP administration of naloxonazine, there
were statistically signiﬁcant effects of treatment [F(4,31)=30.10;L, 50 g/L, 150 g/L, and 250 g/L) in 150 g Wistar rats (P32). Nociceptive thresholds were
ly different from control, according to one-way ANOVAs followed by Duncan's post hoc
m 50 g/L sucrose-treated group; ★, signiﬁcantly different from 150 g/L sucrose-treated
Fig. 3. Long-lasting antinociceptive effect of acute intake (arrow) of sucrose solutions (25 g/L, 50 g/L, 150 g/L, and 250 g/L) in 250 g Wistar rats (P42). Nociceptive thresholds were
recorded using the tail-ﬂick test. Data are presented as the mean±S.E.M.; n=8; *, signiﬁcantly different from control, according to one-way ANOVAs followed by Duncan's post hoc
test; +, signiﬁcantly different from 25 g/L sucrose-treated group; #, signiﬁcantly different from 50 g/L sucrose-treated group;★, signiﬁcantly different from 150 g/L sucrose-treated
group.
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interaction [F(36,83)=29.83; pb0.001]. One-way ANOVAs showed
signiﬁcant differences between groups [F(4,31) varying from 0.84 to
12.02; pb0.001]. The post hoc test showed that naloxonazine (0.25,
1.0 and 4.0 mg/kg) caused an immediate decrease of sucrose-induced
antinociception, as shown in Fig. 5.
4. Discussion
The present results suggest that the acute oral intake of sweet sub-
stances, such as sucrose, by juvenile, young adult and mature adult
rodents induces signiﬁcant analgesic effects. This is surprising, con-
sidering that many of our previous reports suggest that only chronic
intake of sweet substances causes antinociception in adult mammals
(Segato et al., 1997; Irusta et al., 2001; Segato et al., 2005). Interest-
ingly, this effect was prevented by the intraperitoneal administration
of both naloxone (a non-selective opioid receptor antagonist) and
naloxonazine (μ1-opioid receptor antagonist).Fig. 4. Effect of naloxone at (0.25, 1.0, 4.0 mg/kg, IP) on antinociception induced by acute ora
were recorded using the tail-ﬂick test. Data are presented as the mean±S.E.M.; n=8; * sign
250 g/L sucrose), according to repeated-measure ANOVA followed by Duncan's post hoc t
naloxone administration (A), followed by oral acute administration of sucrose solution 10 mOur previous study suggested that sweet substance-induced anti-
nociception is followed by transitory increase in blood glucose (Kishi
et al., 2006); in the present work, we might consider the possibility
that the hypo-analgesic effect of sucrose intake may be partially due
to gustatory pathway activity caused by the contact of palatable
sweet substance with gustatory receptors in the mouth. This point
of view is corroborated by a previous report (Blass and Fitzgerald,
1988) that was performed with another experimental model (using
the hot-plate test) using a protocol in which the authors put drops
of sweet palatable substance on the tongue of rats, which also showed
evidence of sweet substance-induced antinociception. As a matter of
fact, the acute intake of highly concentrated sweet substance seems
to be crucial for the nociceptive threshold increase in our model of
sweet substance-induced antinociception.
In the present work, the temporal curve of the analgesic effect of
sucrose solution intake showed sweet substance-induced antinoci-
ception mainly after acute treatment with more concentrated
(150 g/L and 250 g/L) sucrose solutions. Young rodents brieﬂy showedl intake of sucrose solution (250 g/L) in 250 gWistar rats (P42). Nociceptive thresholds
iﬁcantly different from control group (IP administration of physiological saline followed
est. X, signiﬁcantly different from naloxone (0.25 mg/kg). Arrow represents saline or
in later (B).
Fig. 5. Effect of naloxonazine at (0.25, 1.0, 4.0 mg/kg, IP) on antinociception induced by acute oral intake of sucrose solution (250 g/L) in 250 gWistar rats (P42). Nociceptive thresh-
olds were recorded using the tail-ﬂick test. Data are presented as the mean±S.E.M.; n=8; *, signiﬁcantly different from control group (IP administration of physiological saline
followed 250 g/L sucrose), according to repeated-measure ANOVA followed by Duncan's post hoc test. X, signiﬁcantly different from naloxonazine (0.25 mg/kg). #, signiﬁcantly
different from physiological saline plus tap water. Arrows represent saline or naloxonazine administration (A), followed by oral acute administration of sucrose solution 24 h
later (B).
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sucrose solution (250 g/L), while adult rats displayed long-lasting anti-
nociceptive responses after acute pre-treatment with concentrated
(150 g/L and 250 g/L) sucrose solutions.
A previous report demonstrated that there is a progressive nocicep-
tive threshold decrease 48 h after sweet substance intake, with further
nociceptive threshold elevation after the fourth day of intake, reaching
a maximum effect up to the tenth day of intake (Rebouças et al., 2005;
Segato et al., 2005). Similar oscillations of blood glucose levels suggest
endogenous pain inhibitory system mechanisms that are inﬂuenced
by glucose (Kishi et al., 2006). Interestingly, the present work shows
both short- and long-lasting sucrose-induced antinociception after
acute treatment, suggesting an additional antinociceptive mechanism,
probably the recruiting of endogenous pain inhibitory neural networks
through gustatory system activation. In fact, a previous report showed
evidence that the periaqueductal grey matter sends excitatory inputs
to the solitary tract nucleus (Boscan and Paton, 2005).
In addition, short outputs from the solitary tract nucleus to bulbo-
ponto-mesencephalic links (parabrachial nucleus, ventro-lateral
reticular formation, pericoeruleus neural substrates and raphe nuclei)
and long connections to the spinal cord and diencephalic or telence-
phalic structures, such as the hypothalamus and other limbic structures
(Jean, 1991; Herbert and Saper, 1999), are probably anatomic interfaces
between the gustatory system and endogenous pain inhibitory neural
networks.
It has been suggested that developmental changes in endogenous
analgesic mechanisms account for the age-dependency of sucrose-
induced analgesia (Anseloni et al., 2002). In addition, previous ﬁndings
showed that high afﬁnity κ-opioid receptor binding sites in the spinal
cord increase by three-fold from P2 to P14 rats, with the majority
of this increase occurring on or around P5 (Zhang and Pasternak,
1981). However, in the present study, antinociception was evoked in
adult laboratory animals acutely pre-treated with sucrose, suggesting
that endogenous pain inhibitory mechanisms can be acutely activated.
All nociceptive experiments were performed in the morning; pre-
vious ﬁndings have shown that tail-ﬂick latencies recorded in the early
morning (7 a.m.) show higher antinociceptive responses in comparison
to those recorded at the end of afternoon (5 p.m.). This is probably
because the afternoon is temporally closer to increased activity and
feeding/drinking responses in nocturnal rodents (Segato et al., 2005).Using different sucrose solution concentrations allowed the avoid-
ance of any eventual stressful inﬂuence of the sucrose concentration
on the brain aversion system. In fact, there is evidence suggesting that
stressor stimuli inﬂuence endogenous opioid peptide neurotransmis-
sion (Vaswani et al., 1988). In addition, some studies have shown a
relationship between stress and eating behaviour (Schachter et al.,
1968; Reznick and Balch, 1977).
Although much evidence implies that the endogenous opioid
peptide-mediated system is involved in palatable substance-induced
analgesia in animal models, a recent report suggests the involvement
of both μ1-opioid and 5-HT2A-serotonergic receptors in antinocicep-
tion due to chronic sucrose solution intake (Rebouças et al., 2005)
by group-caged animals.
The study of sucrose-mediated analgesic neurotransmission and
the participation of endogenous opioid peptides and μ1-opioid
receptors may also offer a better understanding of neural mecha-
nisms controlling compulsive food intake and its relationship to
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